Session | ||||||
KL11: Emerging Innovations in Chronic Kidney Disease Treatment: Novel Approaches and Future Directions
| ||||||
Presentations | ||||||
9:15am - 9:35am
Do drugs and uremic toxins compete for renal clearance and exacerbate combormidities? Utrecht University, Netherlands, The 9:35am - 9:45am
Development of hemodialysis membranes for outside-in filtration Department of Advanced Organ Bioengineering and Therapeutics, University of Twente, The Netherlands
9:45am - 9:55am
CORRELATION ANALYSIS OF GLOMERULAR FILTRATION RATE VALUES OBTAINED BY NUCLEAR MEDICINE METHOD VERSUS ESTIMATED MATHEMATICAL EQUATIONS IN KIDNEY RECIPIENTS FROM LIVING AND DECEASED DONORS 1University clinic for nephrology, Faculty of Medicine, University Ss. Cyril and Methodius, Skopje, R.of North Macedonia; 2Institute of Pathophysiology and Nuclear Medicine, Faculty of Medicine, University Ss. Cyril and Methodius, Skopje, R. of North Macedonia; 3University Goce Delcev, Shtip, R.of N. Macedonia
9:55am - 10:05am
THE EMBOLESS® VENOUS CHAMBER EFFICIENTLY REDUCES AIR BUBBLES. A RANDOMIZED STUDY OF CHRONIC HEMODIALYSIS (HD) PATIENTS. Umea University, Sweden
10:05am - 10:15am
Removal efficiency comparisson between acetate and citrate based dialyzate in online hemodiafiltration and expanded hemodialysis. 1Laboratori Experimental de Nefrologia i Trasplantament Renal (LENIT), Fundació Clínic per la Recerca Biomèdica-Institut d'Investigacions Biomèdiques Agustí Pi i Sunyer, Barcelona (IDIBAPS), Spain; 2Nephrology Department, Hospital Clinic de Barcelona, Spain.
10:15am - 10:25am
New polymers as additives in dialysis treatment blended membranes for long term filtration University of Twente, Netherlands, The
10:25am - 10:35am
FREE AMINO ACID SUPPLEMENTATION PREVENTS PROTEIN MODIFICATIONS ASSOCIATED WITH CHRONIC KIDNEY DISEASE 1Institute of Molecular Cardiovascular Research, University Hospital RWTH Aachen, Germany; 2Experimental Vascular Pathology, Cardiovascular Research Institute Maastricht (CARIM), University of Maastricht, The Netherlands
|